Authors:
DUARTE J
LUGNIER C
TORRES AI
PEREZVIZCAINO F
ZARZUELO A
TAMARGO U
Citation: J. Duarte et al., EFFECTS OF VISNAGIN ON CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES AND THEIRROLE IN ITS INHIBITORY EFFECTS ON VASCULAR SMOOTH-MUSCLE CONTRACTION, General pharmacology, 32(1), 1999, pp. 71-74
Authors:
KLINGLER C
ANCELLIN N
BARRAULT MB
MOREL A
BUHLER JM
ELALOUF JM
CLAUSER E
LUGNIER C
CORMAN B
Citation: C. Klingler et al., ANGIOTENSIN-II POTENTIATES VASOPRESSIN-DEPENDENT CAMP ACCUMULATION INCHO TRANSFECTED CELLS - MECHANISMS OF CROSS-TALK BETWEEN AT(1A) AND V-2 RECEPTORS, Cellular signalling, 10(1), 1998, pp. 65-74
Authors:
OKRUHLICOVA L
TRIBULOVA N
STYK J
ECKLY A
LUGNIER C
SLEZAK J
Citation: L. Okruhlicova et al., SPECIES-DIFFERENCES IN LOCALIZATION OF CARDIAC CAMP-PHOSPHODIESTERASEACTIVITY - A CYTOCHEMICAL STUDY, Molecular and cellular biochemistry, 173(1-2), 1997, pp. 183-188
Authors:
BOURGUIGNON JJ
DESAUBRY L
RABOISSON P
WERMUTH CG
LUGNIER C
Citation: Jj. Bourguignon et al., 9-BENZYLADENINES - POTENT AND SELECTIVE CAMP-PHOSPHODIESTERASE INHIBITORS, Journal of medicinal chemistry, 40(12), 1997, pp. 1768-1770
Citation: Ae. Ecklymichel et al., CHELERYTHRINE, A PROTEIN-KINASE-C INHIBITOR, INTERACTS WITH CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES, European journal of pharmacology, 324(1), 1997, pp. 85-88
Authors:
CHULIA S
IVORRA MD
MARTINEZ S
ELORRIAGA M
VALIENTE M
NOGUERA MA
LUGNIER C
ADVENIER C
DOCON P
Citation: S. Chulia et al., RELATIONSHIPS BETWEEN STRUCTURE AND VASCULAR ACTIVITY IN A SERIES OF BENZYLISOQUINOLINES, British Journal of Pharmacology, 122(3), 1997, pp. 409-416
Citation: A. Ecklymichel et al., INVOLVEMENT OF CYCLIC NUCLEOTIDE-DEPENDENT PROTEIN-KINASES IN CYCLIC AMP-MEDIATED VASORELAXATION, British Journal of Pharmacology, 122(1), 1997, pp. 158-164
Authors:
CORMAN B
KLINGLER C
BARRAULT MB
ANCELLIN N
CLAUSER E
LUGNIER C
MOREL A
Citation: B. Corman et al., ANGIOTENSIN-II POTENTIATES THE VASOPRESSIN DEPENDENT CAMP ACCUMULATION IN CHO CELLS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 87-87
Authors:
KLINGLER C
BARRAULT MB
ANCELLIN N
MOREL A
CLAUSER E
LUGNIER C
CORMAN B
Citation: C. Klingler et al., EVIDENCES FOR PHOSPHODIESTERASE INHIBITION IN THE INTERACTIONS BETWEEN VASOPRESSIN AND ANGIOTENSIN-II RECEPTORS, Kidney international, 50(5), 1996, pp. 1803-1803
Authors:
OKRUHLICOVA L
TRIBULOVA N
ECKLY A
LUGNIER C
SLEZAK J
Citation: L. Okruhlicova et al., CYTOCHEMICAL DISTRIBUTION OF CYCLIC-AMP-DEPENDENT 3',5'-NUCLEOTIDE PHOSPHODIESTERASE IN THE RAT MYOCARDIUM, Histochemical Journal, 28(3), 1996, pp. 165-172
Citation: T. Kessler et C. Lugnier, ROLIPRAM INCREASES CYCLIC-GMP CONTENT IN L-ARGININE-TREATED CULTURED BOVINE AORTIC ENDOTHELIAL-CELLS, European journal of pharmacology. Molecular pharmacology section, 290(2), 1995, pp. 163-167
Citation: N. Komas et al., VASCULAR SMOOTH-MUSCLE AND LEFT-VENTRICLE MEMBRANE-BOUND CGMP INHIBITED TYPE-III PHOSPHODIESTERASE (CGI PDE) ARE PHARMACOLOGICAL DIFFERENT FROM SINOATRIAL NODE MEMBRANE-BOUND CGI PDE, The FASEB journal, 9(6), 1995, pp. 1261-1261
Authors:
ROUSSEAU E
DOSTIE J
TAOUDIBENCHEKROUN M
CADIEUX A
BEAUDRY C
LUGNIER C
Citation: E. Rousseau et al., SPECIFIC CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE INHIBITORS DIFFERENTLY MODULATE CONTRACTILE KINETICS IN AIRWAY SMOOTH-MUSCLE, Canadian journal of physiology and pharmacology, 73(12), 1995, pp. 1784-1794
Citation: Ae. Eckly et al., INVOLVEMENT OF PROTEIN KINASE-G IN VASCULAR RELAXATION INDUCED BY THECYCLIC-NUCLEOTIDE PHOSPHODIESTERASE IV INHIBITOR, ROLIPRAM, British Journal of Pharmacology, 114, 1995, pp. 206-206
Authors:
LEROY MJ
LUGNIER C
MEREZAK J
TANGUY G
OLIVIER S
LEBEC A
FERRE F
Citation: Mj. Leroy et al., ISOLATION AND CHARACTERIZATION OF THE ROLIPRAM-SENSITIVE CYCLIC AMP-SPECIFIC PHOSPHODIESTERASE (TYPE-IV PDE) IN HUMAN TERM MYOMETRIUM, Cellular signalling, 6(4), 1994, pp. 405-412
Citation: C. Lugnier et T. Kessler, INFLUENCE OF L-ARGININE ON THE EFFECTS OF INHIBITORS OF CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES (PDE) IN ENDOTHELIAL-CELLS, The FASEB journal, 8(4), 1994, pp. 10000084-10000084
Citation: E. Rousseau et al., BIOCHEMICAL AND PHARMACOLOGICAL CHARACTERIZATION OF CYCLIC-NUCLEOTIDEPHOSPHODIESTERASE IN AIRWAY EPITHELIUM, Molecular and cellular biochemistry, 140(2), 1994, pp. 171-175
Citation: C. Lugnier et al., INHIBITION OF CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES FROM BOVINE AORTA BY PAPAVERINE ANALOGS - A MULTIVARIATE APPROACH, European journal of medicinal chemistry, 29(10), 1994, pp. 723-734
Citation: Ae. Eckly et al., ISOPRENALINE INDUCES ENDOTHELIUM-INDEPENDENT RELAXATION AND ACCUMULATION OF CYCLIC-NUCLEOTIDES IN THE RAT AORTA, European journal of pharmacology, 271(1), 1994, pp. 237-240
Authors:
CHULIA S
IVORRA MD
LUGNIER C
VILA E
NOGUERA MA
DOCON P
Citation: S. Chulia et al., MECHANISM OF THE CARDIOVASCULAR ACTIVITY OF LAUDANOSINE - COMPARISON WITH PAPAVERINE AND OTHER BENZYLISOQUINOLINES, British Journal of Pharmacology, 113(4), 1994, pp. 1377-1385
Citation: Ae. Eckly et C. Lugnier, ROLE OF PHOSPHODIESTERASE-III AND PHOSPHODIESTERASE-IV IN THE MODULATION OF VASCULAR CYCLIC-AMP CONTENT BY THE NO CYCLIC-GMP PATHWAY, British Journal of Pharmacology, 113(2), 1994, pp. 445-450
Citation: J. Gillongo et al., G-PROTEINS IN AORTIC ENDOTHELIAL-CELLS AND BRADYKININ-INDUCED FORMATION OF NITRIC-OXIDE, European journal of pharmacology. Molecular pharmacology section, 247(2), 1993, pp. 119-125
Citation: C. Lugnier et N. Komas, MODULATION OF VASCULAR CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES BY CYCLIC-GMP - ROLE IN VASODILATATION, European heart journal, 14, 1993, pp. 141-148
Authors:
LUGNIER C
MULLER B
LEBEC A
BEAUDRY C
ROUSSEAU E
Citation: C. Lugnier et al., CHARACTERIZATION OF INDOLIDAN-SENSITIVE AND ROLIPRAM-SENSITIVE CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES IN CANINE AND HUMAN CARDIAC MICROSOMAL FRACTIONS, The Journal of pharmacology and experimental therapeutics, 265(3), 1993, pp. 1142-1151